ストックスクリーナーアプリを入手
4.29
15.01%
0.56
プレマーケット:
4.46
0.17
+3.96%
前日終値:
$3.73
開ける：
$3.8
24時間の取引高:
1.08M
Relative Volume:
1.59
時価総額：
$169.44M
収益：
$875.70K
当期純損益:
$-39.57M
株価収益率:
-3.196
EPS:
-1.3423
ネットキャッシュフロー:
$-33.65M
1週間 パフォーマンス:
-5.51%
1か月 パフォーマンス:
+5.41%
6か月 パフォーマンス:
+79.50%
1年 パフォーマンス:
+63.74%
1日の値動き範囲:
$3.74
$4.32
1週間の範囲:
$3.36
$4.97
52週間の値動き範囲:
$1.90
$5.14
Vistagen Therapeutics Inc Stock (VTGN) Company Profile
名前
Vistagen Therapeutics Inc
セクター
電話
650-577-3600
住所
343 ALLERTON AVENUE, SOUTH SAN FRANCISCO
VTGN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
VTGN
Vistagen Therapeutics Inc
|
4.29 | 147.32M | 875.70K | -39.57M | -33.65M | -1.3423 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Vistagen Therapeutics Inc Stock (VTGN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-12-07 | アップグレード | Jefferies | Hold → Buy |
| 2023-08-07 | アップグレード | Maxim Group | Hold → Buy |
| 2022-07-22 | ダウングレード | Jefferies | Buy → Hold |
| 2022-07-22 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2022-07-22 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2021-05-20 | 開始されました | Robert W. Baird | Outperform |
| 2021-02-18 | 開始されました | Jefferies | Buy |
| 2021-01-04 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2018-06-27 | 開始されました | Maxim Group | Buy |
| 2018-02-08 | 繰り返されました | Chardan Capital Markets | Buy |
| 2017-03-28 | 開始されました | Maxim Group | Buy |
すべてを表示
Vistagen Therapeutics Inc (VTGN) 最新ニュース
Why Vistagen Therapeutics Inc. stock is trending among retail tradersJuly 2025 Final Week & Free Community Consensus Stock Picks - Newser
Will Vistagen Therapeutics Inc. stock pay special dividends2025 Year in Review & Reliable Entry Point Trade Alerts - Newser
VistaGen Therapeutics (NASDAQ:VTGN) Stock Price Passes Below 50 Day Moving AverageHere's Why - MarketBeat
VistaGen appoints Nick Tressler as CFO - MSN
Vistagen Appoints Nick Tressler as Chief Financial Officer - PharmiWeb.com
The time has not yet come to remove your chips from the table: Vistagen Therapeutics Inc (VTGN) - Setenews
Vistagen Therapeutics Appoints Nick Tressler as CFO - MarketScreener
Vistagen (VTGN) Appoints New CFO, Nick Tressler - GuruFocus
Vistagen (VTGN) Names Nick Tressler as New CFO - GuruFocus
Vistagen Names Nick Tressler as Chief Financial Officer - Contract Pharma
Vistagen appoints Nick Tressler as chief financial officer - marketscreener.com
Vistagen (Nasdaq: VTGN) appoints CFO Nick Tressler, grants 150,000-share option - Stock Titan
Why retail investors pile into Vistagen Therapeutics Inc. stock2025 Sector Review & Technical Pattern Based Signals - BỘ NỘI VỤ
Vistagen Therapeutics Inc. (VTGN) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Vistagen (VTGN) Presents Promising Data on PH80 for Menopause Sy - GuruFocus
Vistagen presents data on PH80 for menopausal hot flashes treatment By Investing.com - Investing.com Canada
Vistagen Reports Findings on PH80’s Brain and Autonomic Effects in Women with Menopausal Hot Flashes at The Menopause Society 2025 Annual Meeting - Yahoo Finance
Form 8-KCurrent report - ADVFN
Vistagen Reports Fiscal Year 2026 Second Quarter Financial Results and Provides Corporate Update - ADVFN
What analysts say about Vistagen Therapeutics Inc stockTop Performing Stocks & Free ETF and Mutual Fund Comparisons - earlytimes.in
Is Vistagen Therapeutics Inc a good long term investmentTechnical Breakout Signals & High Return Capital Strategies - earlytimes.in
Can Vistagen Therapeutics Inc. stock hit analyst price targetsSwing Trade & Expert Verified Stock Movement Alerts - newser.com
What technical charts say about Vistagen Therapeutics Inc. stockJuly 2025 Intraday Action & AI Forecasted Entry and Exit Points - newser.com
Will Vistagen Therapeutics Inc. stock split attract more investorsJuly 2025 Pullbacks & Expert Verified Movement Alerts - newser.com
ETFs Investing in Vistagen Therapeutics, Inc. Stocks - TradingView
Can Vistagen Therapeutics Inc. stock deliver surprise earnings beatQuarterly Market Review & Long Hold Capital Preservation Plans - newser.com
Will Vistagen Therapeutics Inc. stock deliver shareholder valueQuarterly Market Summary & Stepwise Entry and Exit Trade Signals - newser.com
How Vistagen Therapeutics Inc. stock compares to industry benchmarksQuarterly Market Review & Precise Trade Entry Recommendations - newser.com
Is Vistagen Therapeutics Inc. stock attractive for income investorsGold Moves & AI Driven Stock Movement Reports - newser.com
Is Vistagen Therapeutics Inc. a candidate for recovery play2025 Market Outlook & AI Forecast Swing Trade Picks - newser.com
Using RSI to spot recovery in Vistagen Therapeutics Inc.Market Performance Report & AI Powered Buy and Sell Recommendations - newser.com
Is Vistagen Therapeutics Inc. stock a safe haven assetBear Alert & Low Risk High Win Rate Stock Picks - newser.com
Vistagen Therapeutics: Intranasal Pherines And A Make-Or-Break 2026 (NASDAQ:VTGN) - Seeking Alpha
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Stifel reiterates Buy rating on VistaGen stock, maintains $12 price target - Investing.com Nigeria
Vistagen Therapeutics Inc. stock trend outlook and recovery pathJuly 2025 Rallies & Low Drawdown Investment Strategies - newser.com
Vistagen Therapeutics Inc (VTGN) 財務データ
収益
当期純利益
現金流量
EPS
1.10%
1.10%
大文字化:
|
ボリューム (24 時間):